Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 365

1.

Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.

Yang G, Wu D, Zhu J, Jiang O, Shi Q, Tian J, Weng Y.

Oncol Rep. 2013 Aug;30(2):877-89. doi: 10.3892/or.2013.2532. Epub 2013 Jun 11.

PMID:
23760062
2.

The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells.

Zhu Y, Wu J, Li S, Ma R, Cao H, Ji M, Jing C, Tang J.

Cell Physiol Biochem. 2013;32(5):1225-37. doi: 10.1159/000354521. Epub 2013 Nov 14.

3.

Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.

Shi R, Peng H, Yuan X, Zhang X, Zhang Y, Fan D, Liu X, Xiong D.

J Cell Biochem. 2013 Aug;114(8):1890-900. doi: 10.1002/jcb.24533.

PMID:
23494858
4.

MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.

Zhong S, Li W, Chen Z, Xu J, Zhao J.

Gene. 2013 Nov 15;531(1):8-14. doi: 10.1016/j.gene.2013.08.062. Epub 2013 Aug 29.

PMID:
23994196
5.

miRNA-34a is associated with docetaxel resistance in human breast cancer cells.

Kastl L, Brown I, Schofield AC.

Breast Cancer Res Treat. 2012 Jan;131(2):445-54. doi: 10.1007/s10549-011-1424-3. Epub 2011 Mar 12.

PMID:
21399894
6.

MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.

Shen H, Li L, Yang S, Wang D, Zhong S, Zhao J, Tang J.

Gene. 2016 Nov 15;593(1):84-90. doi: 10.1016/j.gene.2016.08.016. Epub 2016 Aug 11.

PMID:
27523474
7.

miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.

Wang DD, Yang SJ, Chen X, Shen HY, Luo LJ, Zhang XH, Zhong SL, Zhao JH, Tang JH.

Tumour Biol. 2016 Nov;37(11):15315-15324. Epub 2016 Oct 4.

PMID:
27699665
8.

A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.

De U, Chun P, Choi WS, Lee BM, Kim ND, Moon HR, Jung JH, Kim HS.

Int J Oncol. 2014 Jan;44(1):167-76. doi: 10.3892/ijo.2013.2160. Epub 2013 Oct 31.

PMID:
24190517
9.

Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance.

Davis JM, Navolanic PM, Weinstein-Oppenheimer CR, Steelman LS, Hu W, Konopleva M, Blagosklonny MV, McCubrey JA.

Clin Cancer Res. 2003 Mar;9(3):1161-70.

10.

MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.

Shen H, Wang D, Li L, Yang S, Chen X, Zhou S, Zhong S, Zhao J, Tang J.

Gene. 2017 Jan 5;596:110-118. doi: 10.1016/j.gene.2016.10.016. Epub 2016 Oct 13.

PMID:
27746366
11.

A short hairpin DNA analogous to miR-125b inhibits C-Raf expression, proliferation, and survival of breast cancer cells.

Hofmann MH, Heinrich J, Radziwill G, Moelling K.

Mol Cancer Res. 2009 Oct;7(10):1635-44. doi: 10.1158/1541-7786.MCR-09-0043. Epub 2009 Oct 13. Erratum in: Mol Cancer Res. 2010 Jun;8(6):935. Radziwil, Gerald [corrected to Radziwill, Gerald].

12.

miRNA expression patterns in chemoresistant breast cancer tissues.

Lv J, Xia K, Xu P, Sun E, Ma J, Gao S, Zhou Q, Zhang M, Wang F, Chen F, Zhou P, Fu Z, Xie H.

Biomed Pharmacother. 2014 Oct;68(8):935-42. doi: 10.1016/j.biopha.2014.09.011. Epub 2014 Oct 5.

PMID:
25451164
13.

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.

Hu Y, Xu K, Yagüe E.

Breast Cancer Res Treat. 2015 Jun;151(2):269-80. doi: 10.1007/s10549-015-3372-9. Epub 2015 Apr 22.

PMID:
25900794
14.

Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.

Qi X, Chang Z, Song J, Gao G, Shen Z.

Anticancer Drugs. 2011 Jul;22(6):556-62. doi: 10.1097/CAD.0b013e328345b4e7.

PMID:
21637162
15.

[miR-34a may regulate sensitivity of breast cancer cells to adriamycin via targeting Notch1].

Li X, Zhao J, Tang J.

Zhonghua Zhong Liu Za Zhi. 2014 Dec;36(12):892-6. Chinese.

PMID:
25623761
16.

Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.

Ye W, Chang HL, Wang LS, Huang YW, Shu S, Dowd MK, Wan PJ, Sugimoto Y, Lin YC.

Anticancer Res. 2007 Jan-Feb;27(1A):107-16.

17.

Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.

Li J, Xu LZ, He KL, Guo WJ, Zheng YH, Xia P, Chen Y.

Breast Cancer Res. 2001;3(4):253-63. Epub 2001 Apr 2.

18.

Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.

Lv J, Fu Z, Shi M, Xia K, Ji C, Xu P, Lv M, Pan B, Dai L, Xie H.

Biomed Pharmacother. 2015 Feb;69:162-9. doi: 10.1016/j.biopha.2014.11.028. Epub 2014 Nov 25.

PMID:
25661353
19.

REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.

Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H, Date H.

Cancer Gene Ther. 2009 Jan;16(1):65-72. doi: 10.1038/cgt.2008.58. Epub 2008 Jul 25.

PMID:
18654608
20.

Influence of MiR-451 on Drug Resistances of Paclitaxel-Resistant Breast Cancer Cell Line.

Gu X, Li JY, Guo J, Li PS, Zhang WH.

Med Sci Monit. 2015 Oct 30;21:3291-7.

Supplemental Content

Support Center